Why it’s important to continue on VYNDAMAX® (tafamidis) as your doctor prescribed

An older man holding his grandchild to represent someone taking VYNDAMAX (tafamidis) as prescribed once daily

In a clinical trial, VYNDAMAX was proven to significantly reduce death and the number of heart-related hospitalizations in people with ATTR-CM.

It’s important to remember that even if you don’t feel VYNDAMAX working, it can help you live longer with fewer hospital visits.

That’s because ATTR-CM is a disease that gets worse over time. VYNDAMAX works to help slow the progression of the disease by slowing the buildup of dangerous misfolded TTR protein.

A man talking to his doctor about downloadable brochures and additional VYNDAMAX (tafamidis) resources for support

Need help staying on track?

Learn about additional resources and support for VYNDAMAX.

A couple holding hands who might benefit from joining an ATTR-CM advocacy group where they can get support from other patients

Looking to speak to others living with ATTR-CM?

Advocacy groups are available to offer support.